Kihyoun Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout.

A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout.

Journal: Frontiers in immunology

Published: October 05, 2023

Pancreatic β-cell mitophagy as an adaptive response to metabolic stress and the underlying mechanism that involves lysosomal Ca2+ release.

Pancreatic β-cell mitophagy as an adaptive response to metabolic stress and the underlying mechanism that involves lysosomal Ca2+ release.

Journal: Experimental & molecular medicine

Published: March 08, 2023

Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunction.

Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunction.

Journal: Autophagy

Published: October 10, 2022

Essential role of lysosomal Ca2+-mediated TFEB activation in mitophagy and functional adaptation of pancreatic β-cells to metabolic stress.

Essential role of lysosomal Ca2+-mediated TFEB activation in mitophagy and functional adaptation of pancreatic β-cells to metabolic stress.

Journal: Autophagy

Published: April 25, 2022

Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases.

Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases.

Journal: Frontiers in cell and developmental biology

Published: November 09, 2021

Lysosomal Ca2+-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress.

Lysosomal Ca2+-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress.

Journal: Nature communications

Published: April 02, 2021

β-cell autophagy: Mechanism and role in β-cell dysfunction.

β-cell autophagy: Mechanism and role in β-cell dysfunction.

Journal: Molecular metabolism

Published: September 11, 2019

An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer.

An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer.

Journal: Nature communications

Published: September 28, 2018

Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis.

Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis.

Journal: PloS one

Published: June 21, 2017

A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes.

A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes.

Journal: Nature communications

Published: March 22, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026